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The tumor suppressor protein p53 is 
one of the cell’s most important barri-
ers against oncogenic transformation. By 
regulating the expression of thousands of 
genes, either directly or indirectly, p53 pro-
foundly influences cell fate in response to 
stress. Several decades of research have 
established p53 as a transcriptional acti-
vator with high sequence specificity. How-
ever, p53 clearly also represses at least 
as many genes as it activates, if not more. 
Despite this, the mechanism of repression 
is less well characterized than the trans-
activation mechanism by p53. Now, the 
informative study by Huarte et al. (2010) in 
this issue lays the framework for a new and 
elegant mechanism by which p53 globally 
downregulates a large subset of its repres-
sion targets. These authors show that the 
long intergenic RNA-p21 (lincRNA-p21), a 
bona fide downstream target of p53, is a 
key inhibitor of gene expression through 
its interaction with heterogeneous ribonu-
cleoprotein K (hnRNP-K).
Although the first reports of gene 
repression by p53 focused on suppres-
sion of the basal transcriptional machin-
ery, subsequent studies identified more 
precise mechanisms occurring at specific 
genes (reviewed in Laptenko and Prives, 
2006). These include p53 interacting 
with and inhibiting specific transcription 
factors; displacement of specific activa-
tors from promoters due to the presence 
of overlapping binding sites; the recruit-
ment by p53 of chromatin-modifying 
factors, such as histone deacetylases, 
which then block gene expression; and 
the binding of p53 to unique “repression” 
response elements. In addition, p53 may 
also inhibit genes indirectly by activat-
ing transcription of factors that block 
expression of specific genes. Most nota-
bly, many labs have demonstrated that 
the cell-cycle inhibitor p21 (especially 
within the context of Rb-family activa-
tion) is a critical mediator of p53-depen-
dent transcriptional repression (Figure 
1, top) (Barsotti and Prives, 2009, and 
references therein). Recently, studies 
indicate that p53 regulates microRNAs, 
which either degrade mRNA targets or 
inhibit their translation into protein. The 
p53 protein facilitates not only the tran-
scriptional activation of microRNAs but 
also their processing into mature, active 
forms (Figure 1, middle) (Shi et al., 2010). 
Now, Huarte, Rinn, and their colleagues 
(Huarte et al., 2010) add an exciting new 
route through which p53 executes wide-
spread gene repression, specifically by 
activating a long intergenic RNA (Figure 
1, bottom).
LincRNAs are large RNA molecules 
(primary transcript ≥5 kb) that are evo-
lutionarily conserved across mammalian 
genomes. Although these RNAs are tran-
scribed by RNA polymerase II, 5′capped, 
and polyadenylated like normal mRNAs, 
they do not code for proteins (Guttman 
et al., 2009). Previous work by the Rinn 
group suggested that lincRNAs may 
repress transcription by targeting chro-
matin-modifying complexes to specific 
genomic loci (Khalil et al., 2009).
In their new work, Huarte et al. (2010) 
sought to identify specific lincRNAs that 
operate within the p53 pathway. They con-
structed a tiling microarray designed to 
detect the expression of ?400 lincRNAs. 
They then incubated this array with RNA 
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The tumor suppressor protein p53 coordinates the cellular response to stress through regulation 
of gene expression. Now, Huarte et al. (2010) identify a long intergenic noncoding RNA as a new 
player in p53-mediated repression of genes involved in apoptosis.
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isolated from two mouse cell 
lines engineered with control-
lable expression of p53. These 
experiments uncovered sev-
eral lincRNAs that are poten-
tial targets of p53, and the 
authors focused on lincRNA-
p21, named for its proximity 
to the p53-target gene p21. 
Importantly, they confirmed 
that the human ortholog of the 
mouse lincRNA-p21 is con-
served in both sequence and 
regulation.
To ascertain the role of 
lincRNA-p21 within the p53 
pathway, the authors induced 
the p53 response pathway 
and then silenced either p53 
or lincRNA-p21. By compar-
ing microarrary data under 
these two conditions, the 
authors identified a large set 
of genes that are derepressed 
in response to disruption of 
both p53 and lincRNA-p21. 
Moreover, these specific 
genes are highly represented in the 
group of genes normally repressed by 
p53. This is a significant finding because 
it implicates lincRNA-p21 as a potent 
downstream mediator of p53-dependent 
transcriptional repression that acts on a 
very large scale.
As mentioned, p21 itself is also thought 
to inhibit numerous target genes of p53. 
Nevertheless, disruption of lincRNA-p21 
does not alter levels of p21 mRNA or 
protein. Furthermore, genes regulated 
by lincRNA-p21 do not appear to overlap 
with those identified in previous studies 
as targets of p21. These results suggest 
that lincRNA-p21 acts independently of 
p21.
In response to stress, p53 initiates a 
cellular program that often results in cell-
cycle arrest or cell death. Despite the 
large common set of genes regulated by 
p53 and lincRNA-p21, Huarte, Rinn, and 
coworkers found that silencing of lin-
cRNA-p21 blocks programmed cell death 
(i.e., apoptosis) but not cell-cycle arrest. 
LincRNA-p21 represses the expression 
of several important prosurvival factors, 
which may help to explain this interesting 
phenotype. This hypothesis is supported 
by previous studies demonstrating that 
the repression of antiapoptotic genes 
by p53 is crucial for p53-facilitated cell 
death (Ho and Benchimol, 2003). Further, 
Huarte et al. show that the activation of 
certain proapoptotic genes by p53, such 
as Noxa and Perp, depends on lincRNA-
p21. Therefore, lincRNA-p21 may also 
play an important role in determining the 
promoter selectivity of p53 for gene acti-
vation in addition to directing the repres-
sion of target genes.
Next, Huarte and colleagues delved 
into the mechanism by which lincRNA-
p21 represses transcription. With great 
satisfaction, they identify hnRNP-K as 
a key protein partner for lincRNA-p21. 
Best known for its role in chromatin 
remodeling and transcriptional regula-
tion (initiation, elongation, and termina-
tion), hnRNP-K binds to a wide range of 
molecules, including DNA, RNA, protein 
kinases, and factors that remodel chro-
matin. Thus, hnRNP-K also participates 
in diverse processes, such as RNA 
splicing, mRNA stability, and translation 
(Bomsztyk et al., 2004).
After validating the specificity of the 
association between lincRNA-p21 and 
hnRNP-K and identifying the region of 
the RNA necessary for their binding, 
the authors again turned to microar-
ray analyses to assess the importance 
of this interaction. Indeed, a 
large percentage of genes 
commonly inhibited by p53 
and lincRNA-p21 also require 
hnRNP-K for their repression. 
Further, hnRNP-K is recruited 
to promoters for genes that 
are downregulated by the 
p53/ l incRNA-p21/hnRNP-
K axis, and this recruitment 
depends on lincRNA-p21. 
Taken together, these results 
imply that hnRNP-K plays 
a significant and direct role 
in executing gene repres-
sion mediated by p53 and 
lincRNA-p21.
Supporting this model, 
previous studies found that 
hnRNP-K is present in a 
repressive complex with the 
linker histone H1.2. Moreover, 
this complex blocks chromatin 
acetylation and subsequent 
transcriptional activation by 
p53 and the transcription fac-
tor complex p300 (Kim et al., 
2008). In contrast, however, Moumen et 
al. (2005) found that hnRNP-K cooperates 
with p53 as a coactivator of transcription 
in response to DNA damage. In the system 
used by Huarte and colleagues, hnRNP-K 
and lincRNA-p21 have independent roles 
as well, with hnRNP-K sharing an over-
lapping set of target genes with p53 that 
are not regulated by lincRNA-p21. Thus, it 
is not clear that lincRNA-p21 and hnRNP-
K are more closely related than p53 and 
hnRNP-K. Nevertheless, the large amount 
of data generated by the new microarray 
analyses supports a more widespread 
role for hnRNP-K in p53-dependent gene 
repression than in p53-dependent gene 
activation.
The Huarte et al. findings raise several 
key questions. Does the binding part-
ner of hnRNP-K determine whether it 
acts as a positive or negative regulator 
of transcription? For example, does the 
interaction between p53 and hnRNP-K 
serve as a platform for other coactiva-
tors, whereas the association between 
lincRNA-p21 and hnRNP-K favors for-
mation of a repressive complex? This 
model would indeed explain the seem-
ingly contradictory roles of hnRNP-K 
with regard to p53 activity. Further, how 
does lincRNA-p21 influence the binding 
figure 1. Activation for Repression’s sake
Activation of p53 in response to stress triggers expression of three distinct 
classes of targets that silence gene expression in different ways, resulting in 
different cellular outcomes.
(Top) The p21 protein inhibits cyclin-dependent kinases, thereby activating 
the Rb family of proteins and inhibiting the E2F transcription factors. This 
ultimately halts progression of the cell cycle.
(Middle) The microRNA miR-34a degrades or inhibits translation of the mRNAs 
of genes important for both cell-cycle progression and survival.
(Bottom) A new class of p53 targets, exemplified by the long intergenic non-
coding RNA lincRNA-p21, is activated by p53 and then inhibits gene expres-
sion (Huarte et al., 2010). Although the exact mechanism of gene repression 
is unclear, lincRNA-p21 interacts with heterogeneous ribonucleoprotein K 
(hnRNP-K) to downregulate a large group of genes that are repressed by p53, 
including several that are important for cell survival.
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of hnRNP-K to specific genomic loci? 
Is there functional significance to the 
remarkable proximity (?15 kb) of lin-
cRNA-p21 to the p21 gene? If these loci 
are regulated interdependently, they may 
act as a key molecular switch between 
life and death. Finally, given the impor-
tance of lincRNA-p21 to p53-dependent 
cell death, is lincRNA-p21 mutated in 
cancer? Answers to each of these ques-
tions will certainly enrich our under-
standing of the functional relationship 
between p53 and this powerful class of 
regulatory molecules, lincRNAs.
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Stem cells have the immense responsi-
bility of maintaining tissue and organism 
homeostasis over the lifetime of an indi-
vidual. As such, stem cells are speculated 
to have evolutionary characteristics that 
offer protection against acute insults, 
allowing them to survive and to repopu-
late their tissues in the short term. How-
ever, they must also act as self-renew-
ing guardians of the genome to ensure 
maximal integrity of the genomic code 
for future stem cells and their mature tis-
sue progeny. The hematopoietic (blood) 
system is perhaps the best studied tis-
sue in terms of its hierarchical develop-
ment from a small number of long-term 
stem cells that are relatively quiescent, 
to progenitors that proliferate and dif-
ferentiate, and then to mature blood cell 
lineages that are produced by the billion 
each day. Hematopoietic stem cells are 
thought to be resistant to injury including 
DNA damage, which may be related to 
their specific gene expression programs, 
epigenetic factors, or exogenous protec-
tion by the stem cell “niche.” Two new 
reports in Cell Stem Cell from the labora-
tories of Emmanuelle Passegué (Mohrin 
et al., 2010) and John Dick (Milyavsky et 
al., 2010) further our understanding of 
how hematopoietic stem cells respond 
to radiation-induced DNA damage.
So how do quiescent stem cells han-
dle genotoxic insults? Mohrin et al. (2010) 
found that murine hematopoietic stem 
and progenitor cells (HSPCs)—defined as 
bone marrow cells expressing the mark-
ers: lineage−/c-Kit+/Sca-1+/Flk2−—were 
more resistant to apoptosis induced 
by a specific dose of ionizing radiation 
than were more differentiated progenitor 
cells (Figure 1). The unique DNA damage 
response of mouse HSPCs involves the 
tumor suppressor protein p53 and is lost 
when stem cells are forced out of qui-
escence and into the cell cycle by treat-
ment with chemotherapy or cytokines. 
Not only are quiescent HSPCs poised 
to resist apoptosis as evidenced by their 
antiapoptotic gene expression program, 
but they are also able to repair their DNA 
by nonhomologous end joining (NHEJ). 
Repair of DNA damage through homolo-
gous recombination (which has a lower 
error rate than NHEJ) requires that cells 
enter the cell cycle; thus, quiescent stem 
cells must rely on NHEJ as an alterna-
tive. The reliance of quiescent adult tis-
sue stem cells on NHEJ for the repair of 
DNA damage may in fact be a general 
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Stem cells repopulate tissues after injury while also renewing themselves, but this makes them 
vulnerable to genotoxic damage. Mohrin et al. (2010) and Milyavsky et al. (2010) now show that 
mouse and human hematopoietic stem cells make opposing decisions about whether to die or to 
persist in response to DNA damage.
